Brief: ChromaDex Corporation Q2 sales USD 20.323 million
09/08/2023 22:05
Aug 9 (Reuters) - ChromaDex Corporation Q2 sales USD 20.323 million vs. IBES estimate USD 19.2 million. * Q2 operating expenses USD 14.672 million * Q2 gross profit USD 12.356 million * Q2 operating income USD -2.316 million * Q2 net income USD -2.191 million * Q2 EPS USD -0.03
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce